Literature DB >> 17091378

Microbial metabolomics: past, present and future methodologies.

Mlawule R Mashego1, Karl Rumbold, Marjan De Mey, Erick Vandamme, Wim Soetaert, Joseph J Heijnen.   

Abstract

Microbial metabolomics has received much attention in recent years mainly because it supports and complements a wide range of microbial research areas from new drug discovery efforts to metabolic engineering. Broadly, the term metabolomics refers to the comprehensive (qualitative and quantitative) analysis of the complete set of all low molecular weight metabolites present in and around growing cells at a given time during their growth or production cycle. This review focuses on the past, current and future development of various experimental protocols in the rapid developing area of metabolomics in the ongoing quest to reliably quantify microbial metabolites formed under defined physiological conditions. These developments range from rapid sample collection, instant quenching of microbial metabolic activity, extraction of the relevant intracellular metabolites as well as quantification of these metabolites using enzyme based and or modern high tech hyphenated analytical protocols, mainly chromatographic techniques coupled to mass spectrometry (LC-MS(n), GC-MS(n), CE-MS(n)), where n indicates the number of tandem mass spectrometry, and nuclear magnetic resonance spectroscopy (NMR).

Mesh:

Substances:

Year:  2006        PMID: 17091378     DOI: 10.1007/s10529-006-9218-0

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  65 in total

1.  Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens.

Authors:  Timo Birkenstock; Manuel Liebeke; Volker Winstel; Bernhard Krismer; Cordula Gekeler; Maria J Niemiec; Hans Bisswanger; Michael Lalk; Andreas Peschel
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

Review 2.  Metabolomics and malaria biology.

Authors:  Viswanathan Lakshmanan; Kyu Y Rhee; Johanna P Daily
Journal:  Mol Biochem Parasitol       Date:  2010-10-21       Impact factor: 1.759

Review 3.  Towards the engineering of in vitro systems.

Authors:  Christoph Hold; Sven Panke
Journal:  J R Soc Interface       Date:  2009-05-27       Impact factor: 4.118

4.  Analytical strategies for LC-MS-based targeted metabolomics.

Authors:  Wenyun Lu; Bryson D Bennett; Joshua D Rabinowitz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-04-29       Impact factor: 3.205

5.  Individual-based modelling: an essential tool for microbiology.

Authors:  Jordi Ferrer; Clara Prats; Daniel López
Journal:  J Biol Phys       Date:  2008-07-19       Impact factor: 1.365

Review 6.  Mechanisms and evolution of control logic in prokaryotic transcriptional regulation.

Authors:  Sacha A F T van Hijum; Marnix H Medema; Oscar P Kuipers
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

7.  Emerging mass spectrometry techniques for the direct analysis of microbial colonies.

Authors:  Jinshu Fang; Pieter C Dorrestein
Journal:  Curr Opin Microbiol       Date:  2014-07-26       Impact factor: 7.934

8.  Response to adverse conditions in two strains of the extremely halophilic species Salinibacter ruber.

Authors:  Jocelyn Brito-Echeverría; Marianna Lucio; Arantxa López-López; Josefa Antón; Philippe Schmitt-Kopplin; Ramón Rosselló-Móra
Journal:  Extremophiles       Date:  2011-04-03       Impact factor: 2.395

9.  Microbial Metabolomics: From Methods to Translational Applications.

Authors:  Rui Guo; Xialin Luo; Xu Xin; Lian Liu; Xijun Wang; Haitao Lu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Transcriptomic and metabolomic profiling of Zymomonas mobilis during aerobic and anaerobic fermentations.

Authors:  Shihui Yang; Timothy J Tschaplinski; Nancy L Engle; Sue L Carroll; Stanton L Martin; Brian H Davison; Anthony V Palumbo; Miguel Rodriguez; Steven D Brown
Journal:  BMC Genomics       Date:  2009-01-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.